Research has shown that telehealth has the potential for better care at lower costs and with increased convenience, but the issue of paying for this service has yet to be addressed.
Research has shown that telehealth has the potential for better care at lower costs and with increased convenience, but the issue of paying for this service has yet to be addressed. A new commentary from RAND takes a look at the benefits of using telehealth and what research is still needed for telealth payment policies to be created.
Past research has shown that telehealth could increase access for people in underserved areas, save time for patients, and help avoid some visits totally. The problem is that providers have little incentive to use this technology because there is no mechanism to bill for work done outside of in-person visits. Furthermore, within the Medicare system there are limitations on which patients can use the telehealth services that are reimbursed.
"However, despite the push for increased telehealth 'parity' (reimbursing telehealth services in an equivalent fashion to an in-person appointment), we know that suddenly reimbursing all telehealth exactly like in-person visits is dangerous," wrote Shira Fischer, associate physician researcher at RAND.
More research is needed in order to determine in what cases telehealth is a good, safe, and cost-effective option. She added that emerging health payment models, such as accountable care organizations, may hold the greatest potential for telehealth services.
Read the full commentary at RAND: http://bit.ly/1Qev5Zw
Wearable Activity Tracker Data Enhance Patient Assessment in Lung Cancer
March 28th 2024This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 days of using the amuelink wearable device from Sony: metabolic equivalent tasks, distance walked, and steps taken.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for HHS leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More